|
|
Line 78: |
Line 78: |
| {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | | {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} |
| {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | | {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} |
| {{Family tree/end}}
| |
|
| |
| ===Predominantly Antibody Deficiency===
| |
| ====Hypogammaglobulinemia====
| |
| {{Family tree/start}}
| |
| {{Family tree | | | | | | | A01 | | |A01=Predominantly Antibody deficiencies, a: Hypogammaglobulinemia}}
| |
| {{Family tree | | | | | | | |!| | | |}}
| |
| {{Family tree | | | | | | | B01 | | |B01=Serum immunoglobulin assays : IgG, IgA, IgM, IgE}}
| |
| {{Family tree | | | | | | | |!| | | |}}
| |
| {{Family tree | | | | | | | C01 | |C01=IgG, IgA, and/or IgM ↓↓
| |
| → B Lymphocyte (CD19+) enumeration (CMF)}}
| |
| {{Family tree | | |,|-|-|-|-|^|-|-|.| |}}
| |
| {{Family tree | | D01 | | | | | | D02 | |D01=B absent|D02= B >1%}}
| |
| {{Family tree | |!| | | | | |,|-|-|^|-|-|.| | |}}
| |
| {{Family tree | |)| E01 | | F01 | | | | G01 | |E01=X-Linked Agammaglobulinemia|F01=Common Variable Immunodeficiency Phenotype|G01=CD19 deficiency}}
| |
| {{Family tree | |!| | | | |!| | | | | |!| | |}}
| |
| {{Family tree | |)| E02 | |)| F02 | | G02 | |E02=µ heavy chain Def|F02=CVID with no gene defect specified|G02=CD20 deficiency}}
| |
| {{Family tree | |!| | | | |!| | | | | |!| | |}}
| |
| {{Family tree | |)| E03 | |)| F03 | | G03 | |E03=Igα def|F03=PIK3CD mutation(GOF),PIK3R1 deficiency(LOF)|G03=CD21 deficiency}}
| |
| {{Family tree | |!| | | | |!| | | | | |!| |}}
| |
| {{Family tree | |)| E04 | |)| F04 | | G04 | | |E04=Igβ def|F04=PTEN deficiency(LOF)|G04=TRNT1 deficiency}}
| |
| {{Family tree | |!| | | | |!| | | | | |!| | |}}
| |
| {{Family tree | |)| E05 | |)| F05 | | G05 | |E05=BLNK def|F05=CD81 deficiency|G05=NFKB1 deficiency}}
| |
| {{Family tree | |!| | | | |!| | | | | |!| | |}}
| |
| {{Family tree | |)| E06 | |)| F06 | | G06 | | |E06=λ5 def|F06=TACI deficiency|G06=NFKB2 deficiency}}
| |
| {{Family tree | |!| | | | |!| | | | | |!| | |}}
| |
| {{Family tree | |)| E07 | |)| F07 | | G07 | |E07=PI3KR1 def|F07=BAFF receptor deficiency|G07=IKAROS deficiency}}
| |
| {{Family tree | |!| | | | |!| | | | | |!| | |}}
| |
| {{Family tree | |`| E08 | |)| F08 | | G08 | |E08=E47 transcription factor def|F08=TWEAK deficiency|G08=ATP6AP1 deficiency}}
| |
| {{Family tree | | | | | | |!| | | |}}
| |
| {{Family tree | | | | | | |)| F09 | |F09=Mannosyl-oligosaccharide glucosidase deficiency (MOGS)}}
| |
| {{Family tree | | | | | | |!| | | | |}}
| |
| {{Family tree | | | | | | |)| F10 | | |F10=TTC37 deficiency}}
| |
| {{Family tree | | | | | | |!| | |}}
| |
| {{Family tree | | | | | | |`| F11 | | |F11=IRF2BP2 deficiency}}
| |
| {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
| |
| {{Family tree/end}}
| |
|
| |
| ====Other Antibody deficiencies====
| |
|
| |
| {{Family tree/start}}
| |
| {{Family tree | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | |A01=Predominantly Antibody deficiencies. b:Other antibody deficiencies}}
| |
| {{Family tree | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | | | | |B01=Serum Immunolobulin Assays: IgG, IgA, IgM, IgE}}
| |
| {{Family tree | | | | | | | | | |,|-|-|-|-|-|-|+|-|-|-|-|-|.| | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | | C01 | | | | | C02 | | | | C03 | | | | | | | | | | | | | | | |C01=Severe Reduction in Serum IgG and IgA with NI/elevated IgM and Normal Numbers of B cells: Hyper IgM Syndromes|C02=Isotype, Light Chain, or Functional Deficiencies with Generally NI Numbers of B cells|C03=High B cell numbers due to constitutive NF-kB activation}}
| |
| {{Family tree | | | | | | | | |!| | | | | | |!| | | | | |!| | | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | |)| D01 | | | |)| D02 | | |`| D03 | | | | | | | | | | |D01=AID deficiency|D02=Selective IgA deficiency|D03=CARD11 Gain of Function}}
| |
| {{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | |)| E01 | | | |)| E02 | | | | | | | | | | | | | | | | |E01=UNG deficiency|E02=Transient hypogammaglobuliemia of infancy}}
| |
| {{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | |)| F01 | | | |)| F02 | | | | | | | | | | | | | | | | |F01=INO80|F02=IgG subclass deficiency with IgA deficiency}}
| |
| {{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | |`| G01 | | | |)| G02 | | | | | | | | | | | | | | | | |G01=MSH6|G02=Isolated IgG subclass deficiency}}
| |
| {{Family tree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | | | | | | | | |)| F03 | | | | | | | | | | | | | | | | |F03=Specific antibody deficiency with normal Ig levels and normal B cells}}
| |
| {{Family tree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | | | | | | | | |)| G03 | | | | | | | | | | | | | | | |G03=Ig heavy chain muations and deletions}}
| |
| {{Family tree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | | | | | | | | |)| H03 | | | | | | | | | | | | | | | |H03= Kappa chain deficiency}}
| |
| {{Family tree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | |}}
| |
| {{Family tree | | | | | | | | | | | | | | | |`| I03 | | | | | | | | | | | | | | | |I03=Selective IgM deficiency}}
| |
| {{Family tree/end}} | | {{Family tree/end}} |
|
| |
|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2], Ali Akram, M.B.B.S.[3], Anmol Pitliya, M.B.B.S. M.D.[4]
Synonyms and keywords: Immune deficiency; immunity suppression; immunological deficiency; immunosuppression
Overview
Classification
| | | | | | | | | | | | | | | | Immunodeficiency | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Immunodeficiency affecting cellular and humoral Immunity | | Combined immunodeficiency | | Predominantly antibody deficiency | | Diseases of immune dysregulation | | Congenital defects of phagocytes | | Defects in intrinsic and innate immunity | | Auto-imflammatory disorders | | Complement deficiencies | | Phenocopies of primary immunodeficiency (PID) | |
Immunodeficiency Affecting Cellular and Humoral Immunity
| | | | | | | | | Immunodeficiency affecting cellular and humoral immunity | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | CD19 NL: SCID T-ve B+ve | | | | | | | | CD19 ↓: SCID T-ve B-ve | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| SCID T-ve B+ve NK-ve | | | | SCID T-ve B+ve NK+ve | | SCID T-ve B-ve NK-ve | | | | SCID T-ve B-ve NK+ve | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
| | | yc deficiency | | | | | IL7Ra . | | | ADA def | | Microcephaly present | | | Microcephaly absent | | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | JAK-3 def | | | | | CD3D, CD3E, CD247 | | | Reticular dysgenesis | | | | DNA Ligase IV def | | | | RAG1/2 def | |
| | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | CD45 def | | | | | | | | XLF def | | | | DCLRE1C def | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | Coronin-1A def | | | | | | | | DNA PKcs def | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | Winged helix def | | | | | | | | | | | | | | | |
|
Combined Immunodeficiency
| | | | | | | | | | | | | | | | | | | | | | | | | | Combined Immunodeficiency Diseases with associated or syndromic features | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Congenital thromocytopenia | | | | | DNA Repair Defects | | | | Immuno-osseous dysplasias | | | | Thymic Defects with additional congenital anomalies | | | Hyper-IgE syndromes(HIES) | | | Dyskeratosis congenita (DKC) | | | Defects of Vitamin B12 and Folate metabolism | | | Anhidrotic Ectodermodysplasia with ID | | | Others | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Wiskott Aldrich Syndrome | | | | | | Ataxia telangiectasia | | | | | Cartilage Hair Hypoplasia | | | | | DiDeorge Syndrome | | | | Job Syndrome | | | | Dyskeratosis congenita | | | | Transcobalmin 2 deficiency | | | | NEMO deficiency | | | | Purine nucleoside phosphorylase deficiency | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | XL thrombocytopenia | | | | | | Nijmegen breakage Syndrome | | | | | Schimke Syndrome | | | | | TBX1 deficiency | | | | Comel Netherton Syndrome | | | | COATS plus syndrome | | | | Deficiency causing hereditary folate malabsorption | | | | EDA-ID due to IKBA GOF mutation | | | | ID with multiple intestinal atresias | | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | WIP deficiency | | | | | | Bloom syndrome | | | | | MYSM1 deficiency | | | | | Chromosome 10p13-p14 deletion Syndrome | | | | PGM3 deficiency | | | | SAMD9 | | | | Methylene-tetrahydrofolate-dehydrogenase 1 deficiency | | | | | | | | | Hepatic veno-occlusive disease with immunodeficiency | | | | | | | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | ARPC1B deficiency | | | | | | PMS2 deficiency | | | | | MOPD1 deficiency | | | | | {{{ F04 }}} | | | | | | | | | SAMD9L | | | | | | | | | | | | | | Vici Syndrome | | | | | | | | | |
| | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | Immunodeficiency with centromeric instability and facial anomalies(ICF1, ICF2, ICF3, ICF4) | | | | | EXTL3 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | HOIL1 deficiency, HOIP1 deficiency | | | | | | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | MCM4 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Calcium Channel Defects(ORAI-1 deficiency, STIM1 deficiency) | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | RNF168 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Hennekam-lymphangiectasia-lymphedema syndrome | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | POLE1 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | STAT5b deficiency | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | POLE2 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Kabuki Syndrome | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | NSMCE3 deficiency | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | ERCC6L2(Hebo deficiency) | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | Ligase 1 deficiency | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | GINS1 deficiency | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Diseases of Immune Dysregulation
Congenital Defects of Phagocytes
Defects in Intrinsic and Innate Immunity
Auto-imflammatory Disorders
Complement Deficiencies
Phenocopies of Primary Immunodeficiency (PID)
| | | | Phenocopies of PID | | | | |
| | | | | | | | | | | | | | |
| | | | | | | |
| Associated with Somatic Mutations | | | | | Associated with Auto-Antibodies | | |
| | | | | | | | | | | | | | | |
| | | ALPS-SFAS | | | | | | Chronic mucocutaneous candidiasis | |
| |
| | | | | | | | | | | | | | | |
| | | RALD(RAS-associated autoimmune leukoproliferative disease) | | | | | | Adult-onset immunodeficiency with susceptibility to mycobacteria | |
| |
| | | | | | | | | | | | | | | |
| | | Cryopyrinopathy(Muckle-Wells Syndrome) | | | | | | Recurrentt skin infections | |
| |
| | | | | | | | | | | | | | | | |
| | | Hypereosinophilic syndrome due to somatic mutations in STAT5b | | | | | | Pulmonary alveolar proteinosis | | |
| |
| | | | | | | | | | | | | | | |
| | | | | | | | | | Acquired angiooedema | | |
|
| | | | | | | | | | | | | | | |
| | | | | | | | | | Atypical Hemolytic Uremic Syndrome | | |
|
| | | | | | | | | | | | | | | |
| | | | | | | | | | Thymoma with hypogammaglobulinemia | | |
|
References
ca:Immunodeficiència
de:Immundefekt
el:Ανοσολογική ανεπάρκεια
he:כשל חיסוני
Template:WH
Template:WS